132 related articles for article (PubMed ID: 21317817)
1. Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.
Fink AM; Weihsengruber F; Duschek N; Schierl M; Wondratsch H; Jurecka W; Rappersberger K; Steiner A
Melanoma Res; 2011 Apr; 21(2):139-43. PubMed ID: 21317817
[TBL] [Abstract][Full Text] [Related]
2. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
3. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
5. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
6. Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.
Fink AM; Wondratsch H; Lass H; Janauer M; Sevelda P; Salzer H; Jurecka W; Ulrich W; Chott A; Steiner A
Ann Surg Oncol; 2011 Jun; 18(6):1691-7. PubMed ID: 21249455
[TBL] [Abstract][Full Text] [Related]
7. No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.
Bogenrieder T; van Dijk MR; Blokx WA; Ramrath K; Seldenrijk K; Stolz W; van Diest PJ
Histopathology; 2011 Aug; 59(2):318-26. PubMed ID: 21884211
[TBL] [Abstract][Full Text] [Related]
8. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
[TBL] [Abstract][Full Text] [Related]
9. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
[TBL] [Abstract][Full Text] [Related]
10. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
11. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
12. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
Pilko G; Besic N; Zgajnar J; Hocevar M
Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
15. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Nieweg OE
Ann Surg; 2009 Aug; 250(2):301-4. PubMed ID: 19638903
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
19. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
20. Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden.
van Akkooi AC; Spatz A; Eggermont AM; Mihm M; Cook MG
Eur J Cancer; 2009 Nov; 45(16):2736-42. PubMed ID: 19767199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]